Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta | 6 | 2018 | 28 | 1.060 |
Why?
|
| Vasodilation | 6 | 2015 | 19 | 0.960 |
Why?
|
| Stress, Psychological | 4 | 2014 | 254 | 0.780 |
Why?
|
| Aortic Aneurysm, Abdominal | 5 | 2022 | 9 | 0.700 |
Why?
|
| Depression | 4 | 2014 | 481 | 0.690 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2022 | 31 | 0.620 |
Why?
|
| Vascular Diseases | 3 | 2014 | 52 | 0.550 |
Why?
|
| Behavior, Animal | 3 | 2014 | 105 | 0.530 |
Why?
|
| Aortic Rupture | 3 | 2022 | 9 | 0.470 |
Why?
|
| Stents | 7 | 2018 | 85 | 0.450 |
Why?
|
| Vasoconstriction | 2 | 2011 | 25 | 0.450 |
Why?
|
| Metabolic Syndrome | 3 | 2022 | 68 | 0.430 |
Why?
|
| Thromboxane A2 | 3 | 2015 | 4 | 0.410 |
Why?
|
| Blood Vessels | 1 | 2010 | 18 | 0.360 |
Why?
|
| Drug Resistance | 1 | 2010 | 60 | 0.350 |
Why?
|
| Dyslipidemias | 1 | 2010 | 23 | 0.350 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 37 | 0.340 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2022 | 11 | 0.340 |
Why?
|
| Animals | 16 | 2022 | 4724 | 0.340 |
Why?
|
| Aspirin | 1 | 2010 | 87 | 0.330 |
Why?
|
| Microcirculation | 4 | 2022 | 42 | 0.330 |
Why?
|
| Angioplasty, Balloon | 3 | 2008 | 19 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 782 | 0.320 |
Why?
|
| Vascular System Injuries | 2 | 2018 | 5 | 0.300 |
Why?
|
| Nitric Oxide | 5 | 2015 | 103 | 0.290 |
Why?
|
| Endothelium, Vascular | 3 | 2014 | 65 | 0.290 |
Why?
|
| Mice | 7 | 2014 | 1683 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 43 | 0.250 |
Why?
|
| Trachea | 3 | 2018 | 48 | 0.230 |
Why?
|
| Carotid Stenosis | 2 | 2001 | 21 | 0.230 |
Why?
|
| Muscle, Skeletal | 4 | 2022 | 370 | 0.230 |
Why?
|
| Aorta, Abdominal | 2 | 2002 | 6 | 0.220 |
Why?
|
| Hot Temperature | 1 | 2002 | 23 | 0.210 |
Why?
|
| Bandages | 1 | 2002 | 10 | 0.210 |
Why?
|
| Insulin Resistance | 2 | 2015 | 60 | 0.210 |
Why?
|
| Wound Infection | 1 | 2002 | 13 | 0.210 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 14 | 0.210 |
Why?
|
| Male | 20 | 2018 | 16499 | 0.210 |
Why?
|
| Ischemia | 1 | 2002 | 28 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 3 | 2014 | 270 | 0.200 |
Why?
|
| Femoral Artery | 2 | 2018 | 14 | 0.200 |
Why?
|
| Carotid Artery, Internal | 2 | 2001 | 12 | 0.200 |
Why?
|
| Wound Healing | 2 | 2002 | 174 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 443 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2001 | 17 | 0.200 |
Why?
|
| Carotid Artery, Common | 1 | 2001 | 8 | 0.190 |
Why?
|
| Risk Factors | 7 | 2022 | 2593 | 0.180 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2008 | 12 | 0.170 |
Why?
|
| Postoperative Complications | 5 | 2022 | 997 | 0.170 |
Why?
|
| Embolism, Paradoxical | 1 | 1999 | 8 | 0.170 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1999 | 20 | 0.170 |
Why?
|
| Arterioles | 4 | 2015 | 14 | 0.170 |
Why?
|
| Tracheal Diseases | 1 | 2018 | 1 | 0.160 |
Why?
|
| Bioengineering | 1 | 2018 | 1 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 45 | 0.160 |
Why?
|
| Bronchi | 1 | 2018 | 13 | 0.160 |
Why?
|
| Vascular Grafting | 1 | 2018 | 1 | 0.160 |
Why?
|
| Femoral Vein | 1 | 2018 | 4 | 0.160 |
Why?
|
| Saphenous Vein | 1 | 2018 | 9 | 0.160 |
Why?
|
| Bites and Stings | 1 | 2018 | 5 | 0.150 |
Why?
|
| Cryopreservation | 1 | 2018 | 28 | 0.150 |
Why?
|
| Time Factors | 6 | 2022 | 1681 | 0.150 |
Why?
|
| Brain Ischemia | 1 | 1999 | 75 | 0.150 |
Why?
|
| Rats, Zucker | 4 | 2022 | 11 | 0.150 |
Why?
|
| Obesity | 2 | 2022 | 307 | 0.150 |
Why?
|
| Iliac Vein | 1 | 2017 | 5 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 13 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2001 | 818 | 0.140 |
Why?
|
| Sacrum | 1 | 2017 | 29 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 691 | 0.140 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 1935 | 0.140 |
Why?
|
| Receptors, LDL | 3 | 2010 | 7 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2015 | 11 | 0.130 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 9 | 0.130 |
Why?
|
| Treatment Outcome | 9 | 2022 | 3809 | 0.130 |
Why?
|
| Vasodilator Agents | 2 | 2015 | 33 | 0.120 |
Why?
|
| Apolipoproteins E | 3 | 2010 | 270 | 0.120 |
Why?
|
| Humans | 18 | 2022 | 31070 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 82 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 149 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 195 | 0.110 |
Why?
|
| Middle Aged | 10 | 2018 | 10239 | 0.110 |
Why?
|
| Arachidonic Acid | 2 | 2010 | 14 | 0.100 |
Why?
|
| Rats | 3 | 2022 | 873 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 466 | 0.100 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2002 | 24 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 2 | 2002 | 28 | 0.100 |
Why?
|
| Corticosterone | 1 | 2011 | 3 | 0.100 |
Why?
|
| Phenylephrine | 1 | 2011 | 9 | 0.100 |
Why?
|
| Acetylcholine | 1 | 2011 | 12 | 0.100 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 4 | 0.100 |
Why?
|
| Aged | 10 | 2018 | 10079 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 2017 | 523 | 0.100 |
Why?
|
| Fluoxetine | 1 | 2011 | 33 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 17 | 0.090 |
Why?
|
| Hyperlipidemia, Familial Combined | 1 | 2010 | 1 | 0.090 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2010 | 4 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 44 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 31 | 0.090 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2010 | 40 | 0.090 |
Why?
|
| Biomarkers | 2 | 2011 | 733 | 0.090 |
Why?
|
| Pneumonectomy | 2 | 2018 | 88 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 261 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2017 | 562 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 105 | 0.080 |
Why?
|
| Hemostatic Techniques | 1 | 2008 | 9 | 0.080 |
Why?
|
| Manipulation, Orthopedic | 1 | 2008 | 10 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 12 | 0.080 |
Why?
|
| Extremities | 1 | 2008 | 33 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 30 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2008 | 79 | 0.080 |
Why?
|
| Sheep | 3 | 2002 | 42 | 0.070 |
Why?
|
| Thrombosis | 1 | 2008 | 64 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2010 | 534 | 0.070 |
Why?
|
| Inflammation | 1 | 2010 | 362 | 0.070 |
Why?
|
| Hypertension | 1 | 2010 | 288 | 0.070 |
Why?
|
| Female | 11 | 2018 | 17018 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1133 | 0.060 |
Why?
|
| Orthopedic Procedures | 1 | 2008 | 329 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2002 | 5192 | 0.060 |
Why?
|
| Adult | 6 | 2018 | 8949 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2022 | 3665 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 818 | 0.060 |
Why?
|
| Minnesota | 1 | 2002 | 10 | 0.050 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2002 | 5 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2002 | 4 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2002 | 24 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2002 | 29 | 0.050 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2002 | 14 | 0.050 |
Why?
|
| Incidence | 2 | 2002 | 790 | 0.050 |
Why?
|
| Hospitals, Low-Volume | 1 | 2022 | 5 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2002 | 16 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 27 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2002 | 18 | 0.050 |
Why?
|
| Antioxidants | 2 | 2015 | 65 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2002 | 60 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 344 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2001 | 16 | 0.050 |
Why?
|
| Logistic Models | 1 | 2002 | 410 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 12 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 216 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2001 | 30 | 0.050 |
Why?
|
| Arteritis | 1 | 2000 | 3 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2000 | 7 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2001 | 63 | 0.050 |
Why?
|
| Aging | 1 | 2011 | 1727 | 0.050 |
Why?
|
| Tibial Arteries | 1 | 2000 | 1 | 0.050 |
Why?
|
| Popliteal Artery | 1 | 2000 | 4 | 0.050 |
Why?
|
| Embolectomy | 1 | 2000 | 5 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2000 | 54 | 0.050 |
Why?
|
| Endarterectomy, Carotid | 1 | 2000 | 4 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2000 | 35 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2000 | 8 | 0.050 |
Why?
|
| Transplantation, Heterotopic | 1 | 2000 | 8 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2000 | 30 | 0.040 |
Why?
|
| Suction | 1 | 2000 | 48 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2000 | 11 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2000 | 31 | 0.040 |
Why?
|
| Anesthesia, Conduction | 1 | 2000 | 30 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2000 | 58 | 0.040 |
Why?
|
| Tracheal Stenosis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2002 | 356 | 0.040 |
Why?
|
| Autografts | 1 | 2018 | 35 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 264 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 244 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 12 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 35 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2017 | 67 | 0.040 |
Why?
|
| Rats, Inbred SHR | 1 | 2015 | 1 | 0.030 |
Why?
|
| Rats, Inbred Dahl | 1 | 2015 | 1 | 0.030 |
Why?
|
| Hypertension, Renal | 1 | 2015 | 4 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 691 | 0.030 |
Why?
|
| Sodium, Dietary | 1 | 2015 | 8 | 0.030 |
Why?
|
| Fructose | 1 | 2015 | 12 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 22 | 0.030 |
Why?
|
| Vascular Stiffness | 1 | 2015 | 9 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 51 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 8 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2015 | 134 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 88 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 103 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 468 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 699 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2014 | 262 | 0.030 |
Why?
|
| Radiography | 2 | 2008 | 695 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 874 | 0.030 |
Why?
|
| Sex Factors | 1 | 2014 | 510 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 718 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 830 | 0.030 |
Why?
|
| United States | 1 | 1999 | 2375 | 0.030 |
Why?
|
| Stroke | 1 | 2015 | 315 | 0.020 |
Why?
|
| Grooming | 1 | 2011 | 1 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 15 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 10 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2011 | 51 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 141 | 0.020 |
Why?
|
| Transplantation, Autologous | 2 | 2001 | 198 | 0.020 |
Why?
|
| Survival Rate | 2 | 2002 | 407 | 0.020 |
Why?
|
| Hyperemia | 1 | 2009 | 2 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2009 | 8 | 0.020 |
Why?
|
| Automation | 1 | 2009 | 11 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2009 | 41 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 173 | 0.020 |
Why?
|
| Skiing | 1 | 2008 | 1 | 0.020 |
Why?
|
| Knee Dislocation | 1 | 2008 | 7 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 323 | 0.020 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Prostaglandin H2 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Spin Labels | 1 | 2008 | 2 | 0.020 |
Why?
|
| Arteries | 1 | 2008 | 20 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2008 | 5 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 28 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2008 | 43 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2009 | 76 | 0.020 |
Why?
|
| Hematoma | 1 | 2008 | 21 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 370 | 0.020 |
Why?
|
| Shoulder Dislocation | 1 | 2008 | 102 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 416 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 428 | 0.020 |
Why?
|
| Life Tables | 1 | 2002 | 4 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2002 | 78 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 286 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 404 | 0.010 |
Why?
|
| Catheterization | 1 | 2000 | 51 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 2000 | 2 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2000 | 6 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2000 | 14 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 70 | 0.010 |
Why?
|
| Cilia | 1 | 2000 | 2 | 0.010 |
Why?
|
| Metaplasia | 1 | 2000 | 11 | 0.010 |
Why?
|
| Granuloma | 1 | 2000 | 15 | 0.010 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2000 | 10 | 0.010 |
Why?
|
| Epithelium | 1 | 2000 | 29 | 0.010 |
Why?
|
| Angiography | 1 | 2000 | 44 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 2000 | 26 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2000 | 53 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 271 | 0.010 |
Why?
|
| Dyspnea | 1 | 2000 | 44 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 322 | 0.010 |
Why?
|
| Cell Movement | 1 | 2000 | 105 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 232 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2000 | 152 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2000 | 387 | 0.010 |
Why?
|
| Cartilage | 1 | 2000 | 159 | 0.010 |
Why?
|
| Length of Stay | 1 | 2000 | 339 | 0.010 |
Why?
|
| Neoplasms | 1 | 2000 | 261 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2000 | 539 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2000 | 1898 | 0.010 |
Why?
|